Sorry, you need to enable JavaScript to visit this website.

Notice and Order – Conclusion of Benicar Olmesartan Medoxomil Mulitcounty Litigation (MCL)

Notice and Order – Conclusion of Benicar Olmesartan Medoxomil Mulitcounty Litigation (MCL)

In accordance with the provisions of Court Rule 4:38A and Directive #02-19, "Multi county Litigation Guidelines and Criteria for Designation (Revised)," a previous Notice to the Bar sought comments on the recommendation of Superior Court Judge John C. Porto for conclusion of the Benicar Olmesartan Medoxomil ("Benicar") litigation MCL. This Notice is to advise that the Supreme Court, after considering the recommendation and having received no comments objecting to the conclusion, has concluded the MCL designation of all pending and future state-court Benicar litigation. The Court's November 29, 2022 Order is published with this notice.

The notice and order are also posted on the Judiciary's Internet Website in the Multicounty Litigation Information Center.

Questions concerning the Court's conclusion of the MCL designation of the Benicar litigation may be directed to
Melissa A.Czartoryski, Esq.,
Chief, Civil Practice Division,
Administrative Office of the Courts,
Hughes Justice Complex,
P.O. Box 981, Trenton,
New Jersey 08625-0981
telephone:(609) 815-2900 ext. 54900
email address: Melissa. Czartoryski@njcourts.gov.

Document Date: Nov. 29, 2022

Publish Date: Dec. 5, 2022